As global trade tensions escalate, the United States may benefit from applying the concept of precision medicine to strengthen domestic resiliency in the biopharmaceutical industry. This could entail de-risking — without fully severing — drug supply chains with China. For two decades, the economic synergy between China and the United States — often dubbed Chimerica — has driven down drug development costs […]
Author Archives: Jordan Despanie
Jordan Despanie is a technology and security policy fellow at the RAND Corp. He wrote this for InsideSources.com.